Company Filing History:
4 out of 1,744 
3 out of 96 
1 out of 870 
Years Active: 2008-2011
Sure, here is the article for inventor Kostas Kosmatopoulos:
Title: Innovator Spotlight: Kostas Kosmatopoulos Revolutionizing Anticancer Therapy
Introduction:
Kostas Kosmatopoulos, a visionary inventor based in Paris, FR, has made significant contributions to the field of anticancer therapy. With a total of 4 patents to his name, Kosmatopoulos is known for his groundbreaking work in identifying immunogenic peptides derived from the human telomerase reverse transcriptase (hTERT).
Latest Patents:
Kosmatopoulos' latest patent involves polynucleotides encoding MHC class I-restricted hTERT epitopes, analogues thereof, or polyepitopes. This innovation plays a crucial role in the development of effective treatments for cancer by targeting specific epitopes and enhancing the immune response against cancer cells.
Method for screening peptides for use in immunotherapy:
In addition to his groundbreaking patent on hTERT epitopes, Kosmatopoulos has developed a novel method for screening peptides for use in immunotherapy. By identifying subdominant/cryptic epitopes presented by HLA Class I molecules, Kosmatopoulos has paved the way for more targeted and efficient immunotherapy treatments.
Career Highlights:
Throughout his career, Kosmatopoulos has worked with prestigious institutions such as Institut Gustave Roussy and the Institut National De La Sante Et De La Recherche Medicale (INSERM). His dedication to advancing anticancer therapies has earned him recognition as a pioneering figure in the field.
Collaborations:
Kosmatopoulos has collaborated with esteemed professionals in the industry, including Sophie Tourdot and Antonio Scardino. Together, they have worked towards developing innovative solutions for enhancing immunotherapy and cancer treatment strategies.
Conclusion:
In conclusion, Kostas Kosmatopoulos stands out as a leading innovator in the field of anticancer therapy. His patents and research contributions have significantly impacted the landscape of cancer treatment, offering new hope for patients around the world. Kosmatopoulos' dedication to advancing immunotherapy highlights his commitment to improving the lives of those affected by cancer.